Marico Q1 FY26 revenue rose 23%; resurfacing August move to lift Plix owner stake to 60%
Marico reported Q1 FY26 consolidated revenue of Rs 3,259 crore, up 23.3% year on year, while net profit rose 8.2% to Rs 513 crore. India revenue grew 27.2% and international revenue increased 12.9%. Resurfacing a move from early August, the FMCG company also raised its fully diluted stake in Satiya Nutraceuticals, owner of Plix, to 60%.
What happened
Marico posted Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by 27.2% growth in India. It raised its holding in wellness brand Plix owner Satiya
Key facts
- Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY
- Revenue from operations: Rs 3,259 crore, up 23.31% YoY
- India revenue: Rs 2,495 crore, up 27.17% YoY
- International revenue: Rs 764 crore, up 12.91% YoY
- Stake in Satiya Nutraceuticals/Plix increased to 60% on a fully diluted basis
Why this matters
Increasing the fully diluted Plix-owner stake to 60% gives Marico control over a fast-growing nutraceuticals asset and strengthens its position in premium health and wellness.
What to watch
- Plix revenue growth, repeat-purchase rates, offline distribution expansion and profitability after Marico raises its stake to 60%.
- Whether India volume growth remains strong after the Q1 revenue surge, rather than being driven primarily by pricing or channel inventory.
- Gross-margin movement amid copra, edible oil, packaging and other input-cost trends.
- Advertising-and-promotion intensity and whether EBITDA/net-profit growth catches up with revenue growth.
- International business recovery, especially currency effects and demand trends in key overseas markets.
- Further acquisitions or minority-stake increases in health, nutrition and digital-first consumer brands.
- Use Marico's general trade, modern trade and e-commerce network to scale Plix beyond its existing digital-first customer base.
- Increase cross-category launches in protein, functional nutrition and wellness products to capture premium urban consumption.
- Sustain advertising and innovation spending to defend market share in core brands while building newer franchises.
- Pursue deeper operational integration with Satiya Nutraceuticals, including sourcing, supply chain and channel synergies.
- Prioritize margin management through selective pricing, pack architecture and commodity hedging/procurement discipline.